trending Market Intelligence /marketintelligence/en/news-insights/trending/hrbnzdmmoj5xbth6ozhthg2 content esgSubNav
In This List

Bafna Pharmaceuticals reports resignation of 2 directors

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bafna Pharmaceuticals reports resignation of 2 directors

India's Bafna Pharmaceuticals Ltd said that Nirav Maniar resigned as an additional director, effective May 28.

The company also reported the resignation of B Kamlesh Kumar as a director, effective May 20.

Bafna Pharmaceuticals manufactures and sells generic medicines and drugs in Asia, Africa, and the U.K.